Stay updated with breaking news from Oncoextra Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) CFO Jeffrey Thomas Elliott sold 2,710 shares of the business’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $56.89, for a total value of $154,171.90. Following the transaction, the chief financial officer now owns 8,054 shares of the […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 1,880 shares of Exact Sciences stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $56.89, for a total value of $106,953.20. Following the completion of the transaction, the executive vice president now directly owns 73,732 […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 1,021 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $59.72, for a total value of $60,974.12. Following the transaction, the executive vice president now owns 71,658 shares of the company’s stock, […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) insider Jacob A. Orville sold 1,879 shares of the company’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $56.89, for a total value of $106,896.31. Following the sale, the insider now owns 11,754 shares of the company’s stock, […]
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Investment analysts at Leerink Partnrs boosted their Q1 2024 EPS estimates for Exact Sciences in a research note issued to investors on Wednesday, February 21st. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will earn ($0.36) per share for the quarter, up from […]